BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29353549)

  • 21. der(11)t(11;17): a distinct cytogenetic pathway of advanced stage neuroblastoma (NBL) - detected by spectral karyotyping (SKY).
    Stark B; Jeison M; Glaser-Gabay L; Bar-Am I; Mardoukh J; Ash S; Atias D; Stein J; Zaizov R; Yaniv I
    Cancer Lett; 2003 Jul; 197(1-2):75-9. PubMed ID: 12880963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positional and functional mapping of a neuroblastoma differentiation gene on chromosome 11.
    De Preter K; Vandesompele J; Menten B; Carr P; Fiegler H; Edsjö A; Carter NP; Yigit N; Waelput W; Van Roy N; Bader S; Påhlman S; Speleman F
    BMC Genomics; 2005 Jul; 6():97. PubMed ID: 16000168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays.
    George RE; Attiyeh EF; Li S; Moreau LA; Neuberg D; Li C; Fox EA; Meyerson M; Diller L; Fortina P; Look AT; Maris JM
    PLoS One; 2007 Feb; 2(2):e255. PubMed ID: 17327916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroblastoma--clinical applications of molecular parameters.
    Brodeur GM
    Brain Pathol; 1990 Sep; 1(1):47-54. PubMed ID: 1669693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-resolution detection and mapping of genomic DNA alterations in neuroblastoma.
    Mosse YP; Greshock J; Margolin A; Naylor T; Cole K; Khazi D; Hii G; Winter C; Shahzad S; Asziz MU; Biegel JA; Weber BL; Maris JM
    Genes Chromosomes Cancer; 2005 Aug; 43(4):390-403. PubMed ID: 15892104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioinformatics analysis of miRNAs in the neuroblastoma 11q-deleted region reveals a role of miR-548l in both 11q-deleted and MYCN amplified tumour cells.
    Jurcevic S; Keane S; Borgmästars E; Lubovac-Pilav Z; Ejeskär K
    Sci Rep; 2022 Nov; 12(1):19729. PubMed ID: 36396668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma.
    Stallings RL; Carty P; McArdle L; Mullarkey M; McDermott M; O'Meara A; Ryan E; Catchpoole D; Breatnach F
    Cytogenet Genome Res; 2004; 106(1):49-54. PubMed ID: 15218241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma.
    Montemurro L; Raieli S; Angelucci S; Bartolucci D; Amadesi C; Lampis S; Scardovi AL; Venturelli L; Nieddu G; Cerisoli L; Fischer M; Teti G; Falconi M; Pession A; Hrelia P; Tonelli R
    Cancer Res; 2019 Dec; 79(24):6166-6177. PubMed ID: 31615807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of MYCN amplification and chromosome 1p36 loss in neuroblastoma by cDNA microarray comparative genomic hybridization.
    Scaruffi P; Parodi S; Mazzocco K; Defferrari R; Fontana V; Bonassi S; Tonini GP
    Mol Diagn; 2004; 8(2):93-100. PubMed ID: 15527323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MYCN overexpression is associated with unbalanced copy number gain, altered nuclear location, and overexpression of chromosome arm 17q genes in neuroblastoma tumors and cell lines.
    Kuzyk A; Booth S; Righolt C; Mathur S; Gartner J; Mai S
    Genes Chromosomes Cancer; 2015 Oct; 54(10):616-28. PubMed ID: 26171843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MYCN gain and MYCN amplification in a stage 4S neuroblastoma.
    Noguera R; Cañete A; Pellín A; Ruiz A; Tasso M; Navarro S; Castel V; Llombart-Bosch A
    Cancer Genet Cytogenet; 2003 Jan; 140(2):157-61. PubMed ID: 12645655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification.
    Plantaz D; Vandesompele J; Van Roy N; Lastowska M; Bown N; Combaret V; Favrot MC; Delattre O; Michon J; Bénard J; Hartmann O; Nicholson JC; Ross FM; Brinkschmidt C; Laureys G; Caron H; Matthay KK; Feuerstein BG; Speleman F
    Int J Cancer; 2001 Mar; 91(5):680-6. PubMed ID: 11267980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosome 10 abnormality predicts prognosis of neuroblastoma patients with bone marrow metastasis.
    Jiang CY; Xu X; Jian BL; Zhang X; Yue ZX; Guo W; Ma XL
    Ital J Pediatr; 2021 Jun; 47(1):134. PubMed ID: 34108028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma.
    Gehring M; Berthold F; Edler L; Schwab M; Amler LC
    Cancer Res; 1995 Nov; 55(22):5366-9. PubMed ID: 7585602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2(SSTR2) gene at 17q24.
    Abel F; Ejeskär K; Kogner P; Martinsson T
    Br J Cancer; 1999 Dec; 81(8):1402-9. PubMed ID: 10604740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression of ncRAN, a novel non-coding RNA mapped to chromosome 17q25.1, is associated with poor prognosis in neuroblastoma.
    Yu M; Ohira M; Li Y; Niizuma H; Oo ML; Zhu Y; Ozaki T; Isogai E; Nakamura Y; Koda T; Oba S; Yu B; Nakagawara A
    Int J Oncol; 2009 Apr; 34(4):931-8. PubMed ID: 19287950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset.
    Carén H; Kryh H; Nethander M; Sjöberg RM; Träger C; Nilsson S; Abrahamsson J; Kogner P; Martinsson T
    Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4323-8. PubMed ID: 20145112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allelotype of neuroblastoma.
    Takita J; Hayashi Y; Kohno T; Shiseki M; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
    Oncogene; 1995 Nov; 11(9):1829-34. PubMed ID: 7478611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Detection of Genetic Parameters for Prognostic Stratification of Neuroblastoma Using Multiplex Ligation-Dependent Probe Amplification Technique.
    Tumer S; Altungoz O; Bagci O; Olgun HN
    Genet Test Mol Biomarkers; 2016 Feb; 20(2):74-80. PubMed ID: 26790040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular analysis of chromosome arm 17q gain in neuroblastoma.
    Janoueix-Lerosey I; Penther D; Thioux M; de Crémoux P; Derré J; Ambros P; Vielh P; Bénard J; Aurias A; Delattre O
    Genes Chromosomes Cancer; 2000 Jul; 28(3):276-84. PubMed ID: 10862033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.